A new CEO for Graphene@Manchester will lead the commercial development of graphene and 2D materials.
Graphene's high surface area allows us to load items onto the material, allowing it to act as an effective transporter of therapeutic drugs. This could help with the development of cancer treatment, helping to reduce the effects of more invasive remedies such as chemotherapy. Graphene drugs will be able to move quickly through the body and be able to attack cancer cells more effectively, causing less or no damage to healthy cells.
Narrated by Dr Ania Servant, Nanomedicine Network Coordinator, Institute of Inflammation and repair.